Utilization of radiotherapy for rectal cancer in Greater Western Sydney 1994-2001

Asia-Pacific Journal of Clinical Oncology

Volumn 3, Issue 3, 2007, Pages 134-142

  Hegi Johnson, Fiona ^a   Gabriel, Gabriel ^a   Kneebone, Andrew ^a   Wong, Cyril ^b   Jalaludin, Bin ^b,c   Behan, Sharon ^a   Barton, Michael ^a  

^a LIVERPOOL HOSPITAL   (Australia)

^b Southern Sydney Haematology   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Health services research; Radiotherapy; Rectalneoplasms

Indexed keywords

FLUOROURACIL;

AGE; AGED; ARTICLE; AUSTRALIA; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT REFERRAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM CARCINOMA; SOCIOECONOMICS; SURGEON;

EID: 34548248686     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2007.00100.x     Document Type: Article

References (37)

1. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancerbase No. 5, Version 2.0. IARC Press, Lyon 2004.
2. National Cancer Control Initiative. The National Colorectal Care Survey. Cancer Australia, Canberra 2003.
3. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644-50.
4. Kapiteijn E, Marijnen C, Nagtegaal I et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345 (9): 638-46.
5. The Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer (2001). [Cited 24 July 2006.] Available from: http://www.acpgbi.org.uk/download/ colorectal-cancer.pdf.
6. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264 (11): 1444-50.
7. Australian Cancer Network Revision Committee. Clinical Practice Guidelines for the Prevention, Early Detection, and Management of Colorectal Cancer. National Health and Medical Research Council, Canberra 2005.
8. Clinical Oncological Society of Australia, Australian Cancer Network. The Prevention, Early Detection and Management of Colorectal Cancer. National Health and Medical Research Council, Canberra 1999.
9. Abraham NS, Gossey JT, Davila JA, Al-Oudat S, Kramer JK. Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol 2006; 101 (6): 1320-8.
10. McGory NL, Zingmond DS, Sekeris E, Bastani R, Ko CY. A patient's race/ ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer. Dis Colon Rectum 2006; 49 (3): 319-29.
11. Penninckx F, Van Eycken L, Michiels G et al. Survival of rectal cancer patients in Belgium 1997-1998 and the potential benefit of a national project. Acta Chir Belg 2006; 106 (2): 149-57.
12. Phelip JM, Launoy G, Colonna M et al. Regional variations in management of rectal cancer in France. Gastroenterol Clin Biol 2004; 28 (4): 378-83.
13. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of the evidence- based clinical guidelines. Cancer 2005; 104 (6): 1129-37.
14. Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: A review of the evidence. Cancer 2004; 101 (4): 657-70.
15. Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. An evidence- based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys 2003; 56 (5): 1295-307.
16. Church J, Gibbs P, Chao M, Tjandra J. Optimizing the outcome for patients with rectal cancer. Dis Colon Rectum 2003; 46 (3): 389-402.
17. Wigg D, Morgan G. Radiation oncology in Australia: Workforce, workloads and equipment 1986-1999. Australas Radiol 2001; 45 (2): 146-69.
18. Vulto JC, Louwman WJ, Poortmans PM, Coebergh JW. Hospital variation in referral for primary radiotherapy in Southern Netherlands, 1988-1999. Eur J Cancer 2005; 41 (17): 2722-7.
19. Barton MB, Gabriel GS, Miles S. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services. ANZ J Surg 2004; 74 (6): 406-12.
20. Australian Bureau of Statistics (ABS). Income Distribution, Australia, 1996-97. Cat. No. 6523.0. ABS, Canberra 1998.
21. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th edn. Springer-Verlag, New York 2002.
22. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002; 94 (5): 334-57.
23. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001; 93 (11): 850-7.
24. Peeters KC, van de Velde CJ. Surgical quality assurance in rectal cancer treatment: The key to improved outcome. Eur J Surg Oncol 2005; 31 (6): 630-5.
25. Wexner SD, Rotholtz N. Surgeon influenced variables in resectional rectal cancer surgery. Dis Colon Rectum 2000; 43 (11): 1606-27.
26. Jatzko GR, Jagoditsch M, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. Long-term results of radical surgery for rectal cancer: Multivariate analysis of prognostic factors influencing survival and local recurrence. Eur J Surg Oncol 1999; 25 (3): 284-91.
27. Kapiteijn E, Marijnen CA, Colenbrander AC et al. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: A population-based study in the west Netherlands. Eur J Surg Oncol 1998; 24 (6): 528-35.
28. Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004; 47 (7): 1145-9.
29. Kapiteijn E, Putter H, van de Velde CJ, Cooperative Investigators of the Dutch Colorectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg 2002; 89 (9): 1142-9.
30. Armstrong K, O'Connell DL, Leong D, Spigelman AD, Armstrong BK. The New South Wales colorectal cancer care survey-Part 1 surgical management. The Cancer Council 2004.
31. Stocchi L, Nelson H, Sargent DJ et al. (North Central Cancer Treatment Group). Impact of surgical and pathological variables in rectal cancer: a United States Community and Cooperative Group Report. J Clin Oncol 2001; 19: 3895-902.
32. Gastrointestinal Tumor Study Group. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992; 10: 549-57.
33. Krook JE, Moertel CG, Gunderson LL et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324 (11): 709-15.
34. Ngan S, Ngan SY, Burmeister BH, Fisher R. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: A Phase II trial for the Trans-Tasman Radiation Oncology group. Int J Radiat Oncol Biol Phys 2001; 50 (4): 883-7.
35. Au HJ, Mulder KE, Fields AL. Systematic review of management of colorectal cancer in elderly patients. Clin Colorectal Cancer 2003; 3 (3): 165-71.
36. Vironen JH, Sainio P, Husa AI, Kellokumpu IH. Complications and survival after surgery for rectal cancer in patients younger than and aged 75 years or older. Dis Colon Rectum 2004; 47 (7): 1225-31.
37. Vulto AJ, Lemmens VE, Louwman MW et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995-2002. Cancer 2006; 106 (12): 2734-42.